Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-11-12, Stock:ABBV, The news for the past five days is as follows:
2019-11-05: NEWS1: Vanguard Health Care Fund Sells Out of Allergan.NEWS2: Allergan (AGN) Meets Q3 Earnings Estimates, Ups '19 Sales View.NEWS3: Allergan's Q3 Sales Get A Facelift From Botox; AbbVie Deal On Track.NEWS4: The Zacks Analyst Blog Highlights: Group 1 Automotive, AbbVie, Brinker International, Hewlett Packard and Bristol-Myers Squibb.NEWS5: [video]Allergan Tops Q3 Earnings, Bumps 2019 Sales Guidance Amid AbbVie Takeover.NEWS6: Allergan Tops Q3 Earnings, Bumps 2019 Sales Guidance Amid AbbVie Takeover.
2019-11-06: NEWS1: AbbVie Announces Launch of Private Offering of Senior Unsecured Notes.NEWS2: Should You Worry About AbbVie Inc.'s (NYSE:ABBV) CEO Pay Cheque?.
2019-11-07: NEWS1: Zacks.com featured highlights include: Group 1 Automotive, AbbVie, Brinker International, Hewlett Packard Enterprise and Bristol-Myers Squibb.NEWS2: AbbVie Inc. -- Moody's assigns Baa2 to AbbVie's new sr. notes; stable outlook.
2019-11-08: NEWS1: Psst! Want the Secret to Picking Winning Stocks? Keep Reading..NEWS2: 10 Medical Marijuana Stocks to Cure Your Portfolio.NEWS3: AbbVie Submits Supplemental New Drug Application to U.S. FDA For IMBRUVICA® (ibrutinib) in Combination with Rituximab for the Treatment of Previously Untreated, Younger Adults with Chronic Lymphocytic Leukemia.NEWS4: AbbVie Rises 3%.NEWS5: AbbVie Announces Results of Early Participation in Exchange Offers and Consent Solicitations for Allergan Notes.
2019-11-11: NEWS1: Top Research Reports for Toyota, Netflix & AbbVie.NEWS2: Mario Gabelli Continues to Buy AbbVie, Axalta.NEWS3: AbbVie Eyes Approval for Imbruvica+Rituxan in First-Line CLL.

Answer: Rise